Learning Objectives
Define a dosage regimen and explain its purpose in pharmacotherapy. Differentiate between the loading dose and the maintenance dose. Apply the formulas for: loading dose,
Maintenance dose: . Describe the concept of steady state and the role of half-life in achieving it. Explain how clearance, bioavailability, and volume of distribution influence dosage design. Interpret how the therapeutic window (MEC–MTC) determines dose size and frequency.
Dosage Regimens
A dosage regimen is a structured plan for administering a drug over time to achieve and maintain therapeutic plasma concentrations while avoiding toxicity.
The goal is to maintain drug levels within the therapeutic window—above the minimum effective concentration (MEC) and below the minimum toxic concentration (MTC).
To accomplish this, two types of doses are used:
Maintenance Dose (MD)
Maintenance dosing keeps plasma concentrations stable during long-term therapy.
- : desired steady-state concentration
- : clearance
- : bioavailability
Key Principle:
Steady state is governed by the rate of drug elimination, not by the dose size.
Loading Dose (LD)
Used to reach therapeutic plasma levels quickly, especially for drugs with long half-lives.
- : volume of distribution
- : bioavailability
Purpose:
The loading dose “fills” the volume of distribution rapidly, allowing the drug to reach CssC_{ss} much sooner than waiting for steady state.
Steady State (C_ss)
- Reached after 4–5 half-lives with first-order kinetics.
- Determined by infusion rate and clearance.
- Independent of dose magnitude.
Therapeutic Window
- Upper limit: MTC
- Lower limit: MEC
- Dosing must remain between these limits to optimize efficacy and avoid toxicity.
Role of Half-Life
- Longer half-life → fewer doses, may require LD.
- Shorter half-life → more frequent dosing to avoid falling below MEC.








